James K.Williams have been at Wake Forest University for 30 years. During that time, his research focus has been women health. While now a faculty member of Regenerative Medicine, his past research focused on the use of animal models to explore the effects of aging and sex hormones on the cardiovascular and urogenital systems. When moving to the Wake Forest Institute for Regenerative Medicine (WFIRM), his focus remained on women health and was funded for 4 years and now funded for an additional 4 years to explore the utility of cell therapy for urinary incontinence by using nonhuman primates as the animal model.
Dr. Basmaji, is a Brazilian physicist, inventor of artificial natural extracellular matrix for the manufacture of three-dimensional advanced wound management, Tissue engineering, Regenerative medicine, stem cell, Bionanotechnology, Drug deliveryand artificial cartilage grafts.Dr.Basmaji has also experience on Engineering and Bionanotechnology, Drug delivery processing for Health applications, and other process industries worldwide.
Pierre Basmaji(Research Area)
Diabetic foot, burn, wound, cartilage tissue and Regenerative medicine.
Dr. Anand Ramamurthi, PhD is an Associate Staff Professor at the Department of Biomedical Engineering of the Lerner Research Institute at the Cleveland Clinic in Cleveland OH. In parallel he has appointments as adjunct Associate Professor in the Department of Biomedical Engineering at Case Western Reserve University Cleveland OH and at the Department of Bioengineering at Clemson University Clemson SC. He was previously a tenured Associate Professor at the Department of Bioengineering at Clemson University (2003-2010). He received his MS and PhD in Chemical Engineering from Oklahoma State University Stillwater OK in 1996 and 1999 respectively and a BE Hons in Chemical Engineering from Bangalore University India in 1994. He was an American Heart Asssociation postdoctoral fellow at the Cleveland Clinic between 199 and 2001. He has 30 peer reviewed publications to date serves on the editorial board of several journals and is a reviewer for several journals including the Int J of Pharmaceutics J of Heart Valve Disease J of Biomaterials Science J of Biomechanics Anatomical Record Biomaterials Biomacromolecules Biochemie; J of Vascular Disease Tissue Engineering Tissue Engineering and Regenerative Medicine and Histology and Histopathology.
Anand Ramamurthi(Research Area)
Tissue Engineering, Cardiovascular Regenerative Medicine, Biomimetic Matrix Assembly, Elastin Pathology and Elastic Matrix Regenerative Repair, Therapies for Vascular Aneurysms, Blood-Material Compatibility, Glycosaminoglycan- Based Biomaterials, Stem Cells.
Dr Abbas Amini is an assistant professor at ACK, of Western Sydney University graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and committee member of 14 international conferences.
Alexander Khalyavkin is the Academic Secretary of Gerontological Society of RAS (Moscow Branch), Senior Researcher of the Emanuel Institute of Biochemical Physics of RAS and Senior Researcher of the Institute for Systems Analysis of FRC CSC RAS. His Alma Mater was the Moscow Institute of Physics and Technology (the Russian MIT). His postgraduate training was at the Gamaleya Institute for Epidemiology and Microbiology (Moscow). He has completed his PhD in Immunology at 1980. He is author and lecturer of â€œIntroduction to Biogerontologyâ€ for the Moscow Institute of Physics and Technology (1991-2000). He cooperated with the Max Planck Institute for Demographic Research (2001-2009). His research interests include theoretical aspects of biomedicine, biogerontology, biodemography, an effect of environmental factors on the rate of aging, and some aspects of the regulation of reproduction of normal and malignant cells. He studied non-canonical (growth control) function of the immune system and mechanism for a switching of symmetric to asymmetric mitosis in stem cells.
Alexander Khalyavkin(Research Area)
Theoretical aspects of Biomedicine, Biogerontology, Biodemography, an effect of environmental factors on the rate of aging and some aspects of the regulation of reproduction of normal and malignant cells.
Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronicâ€“Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, LASER, Antiâ€“Cancer Nano Drugs, Nano Drugs Delivery, ATRâ€“FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than one hundred fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Italy, Austria, Hungary, Poland, Spain, Portugal, Mexico, Japan, Malaysia, Thailand, Taiwan, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than seven hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than two hundreds reputed international academicâ€“scientificâ€“research institutes around the world. In addition, he is member of the Nobel committee for Chemistry. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.
Alireza Heidari(Research Area)
Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, LASER, Anti Cancer Nano Drugs, Nano Drugs Delivery, ATR FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells.
Ridha HAMBLI is currently a Professor of Biomechanics at PRISME Lab in Polytechnic Institute of Orleans in France. He studied Mechanical engineering at Ecole Centrale de Nantes, France and he received his doctoral degree in 1996 from Ecole National Superieur des Arts et Metiers of Angers, France. Subsequently, he worked as a project manager in from Ecole National Superieur des Arts et Metiers for two years and than as associate professor at Institut des Sciences et Techniques d'Angers - France. In 2006, he moved to Polytechnic Institute of Orleans as a full professor where he was involved in teaching and research activities related to biomechanics and mechanobiology of bone. He is an author of about 200 refereed publications and abstracts in international scientific journals and conference proceedings. He organized several research events and symposiums in relation with his research activities and he acts as a reviewer in several international journals. He also acts as reviewer expert for several organizations in the field of biomechanics.
Ridha Hambli(Research Area)
Biomechanics,Mechanobiology of bones,Mechanical Engineering
Andrzej Lange graduated with a medical degree with distinction from the Medical School in Wroclaw, Poland, where he also completed his doctor of medical sciences thesis and then after a critical review of his scientific activity received the title of doctor habilitatus. He served as an assistant and then associate professor in the Department of Internal Diseases and then Occupational Diseases, where he founded the Laboratory of Clinical Immunology. In 1980 he was offered a position in the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences, where he has worked until now as the professor and head of the Laboratory and Department of Clinical Immunology. His international experience started in 1973 as a Leverhulme Fellow in the Department of Immunology of Middlesex Hospital Medical School, London, where he worked under the guidance of Professor Ivan Roitt. During an eight-year period he used to spend three months yearly as a visiting scientist in the Institute of Experimental Medicine and Biology in Borstel, FRG, headed at that time by Professor Han-Dieter Flad. He has been a short term-visitor and lectured in a number of European and North American scientific institutions including the Mount Sinai School of Medicine and Paris University.
Andrzej Lange(Research Area)
Clinical Immunology,Internal medicine,Immunogenetics (HLA and immune response, genomic DNA typing in pathology studies and bone marrow donor prospecting, standardization and quality assurance of HLA typing), cellular immunology (cytokine-dependent regulation of the NK cell system), autoimmune diseases (pathomechanism and diagnosis) immunotoxicology (aromatic hydrocarbons and immunomodulatory properties of asbestos fibers, carcinogenesis), bone marrow transplants (allogeneic transplants in hematologic disorders, aplastic anomalies and congenital malformations, immune reconstitution and GvH)
Peter K. Law has been a Canadian citizen and was a US permanent resident, with B.Sc (Hons.) from McGILL University, M.Sc., Ph.D. from the University of Toronto, and post-doctorate from McMaster University. He was an Assistant Professor of Neurology at Vanderbilt University, Associate and Full Professor with tenure of Neurology and Physiology/ Biophysics at the University of Tennessee, Memphis. In 1991, he founded the non-profit Cell Therapy Research Foundation in USA to focus on clinical trials on muscular dystrophy (MD) using myoblasts. Upon the recommendation of the Chinese Consulate General in Toronto in year 2009, he was received by the Chairmen ,Prime Ministers and other leaders of China. He founded the Cell Therapy Institute in Wuhan and have been a scholar of the China 1000 Plan and Wuhan 3551 Program.He has been an invited speaker to national academies, health ministries, universities, The White House, The Kremlin and pharmaceutical companies. He reviewed grants for NIH, NSF and others. He has been an editor-in-chief, sectional editor-in-chief and a manuscript reviewer for reputable journals. He chaired many scientific sessions in international conferences, and various committees in the University Senate.
Peter K. Law(Research Area)
cell therapy,genome therapy, angiomyogenic cell therapies to treat debilitating and fatal diseases such as muscular dystrophies, cancer, heart diseases, Type II diabetes and aging. He pioneered and hold world patents on the Human Myoblast Genome Therapy, a platform technology in Regenerative Medicine.